|

Metoprolol Succinate Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Also known as: Lopressor, Toprol-Extended Release (XL)

Pipeline

Phase 4: 2

Top Sponsors

  • University of Rochester1
  • University of Michigan1

Indications

  • Heart Disease2
  • Beta-blocker Therapy1
  • Implantable Cardioverter Defibrillator (ICD)1
  • Ventricular Arrhythmia1
  • Heart Failure With Reduced Ejection Fraction (HFrEF)1

Scottsdale, Arizona1 trial

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

HonorHealth

Phase 4

Ann Arbor, Michigan1 trial

Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score

University of Michigan

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.